drugset / Trial / NCT00578773

A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea

NCT00578773

Phase 2 Completed 303 enrolled Alcon Research
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine if an otic formulation is safe and effective in treating peri-operative tube otorrhea.

Timeline

Start
2007-11
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxidex Unknown Topical
Comparator Moxifloxacin Small molecule Topical

Indications